Buglioni A - Search Results

1

Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndrome.

Guerra F, Mancinelli L, Buglioni A, Pierini V, Rappelli A, Dessì-Fulgheri P, Sarzani R. Guerra F, et al. Among authors: buglioni a. High Blood Press Cardiovasc Prev. 2011 Dec 1;18(4):195-201. doi: 10.2165/11593650-000000000-00000. High Blood Press Cardiovasc Prev. 2011. PMID: 22283674

2

Plasma aldosterone is increased in class 2 and 3 obese essential hypertensive patients despite drug treatment.

Sarzani R, Guerra F, Mancinelli L, Buglioni A, Franchi E, Dessì-Fulgheri P. Sarzani R, et al. Among authors: buglioni a. Am J Hypertens. 2012 Jul;25(7):818-26. doi: 10.1038/ajh.2012.47. Epub 2012 May 3. Am J Hypertens. 2012. PMID: 22552267

3

Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

Buglioni A, Cannone V, Cataliotti A, Sangaralingham SJ, Heublein DM, Scott CG, Bailey KR, Rodeheffer RJ, Dessì-Fulgheri P, Sarzani R, Burnett JC Jr. Buglioni A, et al. Hypertension. 2015 Jan;65(1):45-53. doi: 10.1161/HYPERTENSIONAHA.114.03936. Epub 2014 Nov 3. Hypertension. 2015. PMID: 25368032 Free PMC article.

4

Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up.

Buglioni A, Cannone V, Sangaralingham SJ, Heublein DM, Scott CG, Bailey KR, Rodeheffer RJ, Sarzani R, Burnett JC. Buglioni A, et al. J Am Heart Assoc. 2015 Dec 23;4(12):e002505. doi: 10.1161/JAHA.115.002505. J Am Heart Assoc. 2015. PMID: 26702078 Free PMC article.

5

Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.

Cannone V, Buglioni A, Sangaralingham SJ, Scott C, Bailey KR, Rodeheffer R, Redfield MM, Sarzani R, Burnett JC Jr. Cannone V, et al. Among authors: buglioni a. Mayo Clin Proc. 2018 Aug;93(8):980-990. doi: 10.1016/j.mayocp.2018.05.027. Mayo Clin Proc. 2018. PMID: 30077215 Free PMC article.

6

Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.

Buglioni A, Burnett JC Jr. Buglioni A, et al. Clin Chim Acta. 2015 Mar 30;443:3-8. doi: 10.1016/j.cca.2014.10.027. Epub 2014 Oct 23. Clin Chim Acta. 2015. PMID: 25445413 Free PMC article. Review.

7

New Pharmacological Strategies to Increase cGMP.

Buglioni A, Burnett JC Jr. Buglioni A, et al. Annu Rev Med. 2016;67:229-43. doi: 10.1146/annurev-med-052914-091923. Epub 2015 Oct 14. Annu Rev Med. 2016. PMID: 26473417 Review.

8

A gut-heart connection in cardiometabolic regulation.

Buglioni A, Burnett JC Jr. Buglioni A, et al. Nat Med. 2013 May;19(5):534-6. doi: 10.1038/nm.3196. Nat Med. 2013. PMID: 23652101 Free PMC article.

9

PTH: Potential role in management of heart failure.

Gruson D, Buglioni A, Burnett JC Jr. Gruson D, et al. Among authors: buglioni a. Clin Chim Acta. 2014 Jun 10;433:290-6. doi: 10.1016/j.cca.2014.03.029. Epub 2014 Apr 1. Clin Chim Acta. 2014. PMID: 24704306 Review.

10

De novo pauci-immune glomerulonephritis in renal allografts.

Buglioni A, Fidler ME, Alexander MP, Sethi S, Nasr SH, Hernandez LPH, Grande JP, Cosio FG, Cornell LD. Buglioni A, et al. Mod Pathol. 2020 Mar;33(3):440-447. doi: 10.1038/s41379-019-0355-0. Epub 2019 Sep 2. Mod Pathol. 2020. PMID: 31477812 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page